Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

Market Cap	12.66B
Revenue (ttm)	4.91B
Net Income (ttm)	697.36M
Shares Out	895.24M
EPS (ttm)	0.77
PE Ratio	18.28
Forward PE	15.37
Dividend	0.50 (3.54%)
Ex-Dividend Date	Jul 4, 2024

Volume	25,338,937
Average Volume	15,491,499
Open	14.21
Previous Close	14.30
Day's Range	14.15 - 14.56
52-Week Range	11.83 - 18.41
Beta	0.35
RSI	56.88
Earnings Date	Apr 11, 2025

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization company in China and internationally. The company offers small molecule chemical drugs, peptide drugs, conjugated drugs, and small nucleic acid drugs. It serves global pharmaceutical companies, biotechnology companies, and research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1973
• Employees: 4,877
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603456

Financial Performance

In 2023, SHA:603456's revenue was 5.52 billion, an increase of 1.44% compared to the previous year's 5.45 billion. Earnings were 1.03 billion, an increase of 12.17%.